Crossover Bioequivalence Study of Irbesartan Hydrochlorothiazide 300/25 mg Tablets Under Fed Conditions

NCT01712126 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Irbesartan and Hydrochlorothiazide
DRUG: Avalide

Sponsor

Roxane Laboratories